CytomX Therapeutics, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by CytomX Therapeutics, Inc. (CTMX) on April 28, 2020, reporting events occurring on April 27, 2020. The filing addresses corporate governance changes specifically regarding the Board of Directors.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. This report is limited to the appointment of a director and associated compensatory arrangements.
Material Changes
On April 27, 2020, Halley Gilbert was appointed to the Board of Directors as a Class III director, effective immediately, to fill a vacancy. Her initial term expires at the 2021 annual meeting of stockholders.
Compensatory Arrangements and Governance
- Equity Grant: Ms. Gilbert received an option to purchase 40,000 shares of common stock under the 2015 Equity Incentive Plan.
- Exercise Price: Set at the closing price of the Company's common stock on April 27, 2020.
- Vesting Schedule: The option vests monthly, with 1/36th of the shares becoming exercisable on each monthly anniversary of the appointment date, contingent on continued service.
- Other Compensation: Ms. Gilbert will receive standard non-employee director compensation as outlined in the preliminary proxy statement filed on April 17, 2020.
- Indemnification: The Company entered into a standard indemnification agreement with Ms. Gilbert.
The Company confirmed no transactions exceeding $120,000 involving Ms. Gilbert since the beginning of the last fiscal year and no other arrangements regarding her appointment.
Investor Verification Checklist
- Verify the closing stock price on April 27, 2020, to determine the exercise price of the 40,000 share option.
- Review the preliminary proxy statement filed on April 17, 2020, for details on standard non-employee director cash compensation.
- Confirm the total number of authorized shares under the 2015 Equity Incentive Plan to assess dilution impact.
- Check subsequent filings for the outcome of the 2021 annual meeting regarding Ms. Gilbert's re-election.